Clear Street Markets LLC Incyte Corp Transaction History

Clear Street Markets LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $10,051 - $11,471	174 Added 72.2%	415 $24,000
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $7,374 - $9,136	-121 Reduced 33.43%	241 $15,000
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $12,290 - $15,051	175 Added 93.58%	362 $26,000
Q4 2022 Feb 13, 2023	SELL	$67.18 - $84.11 $5,307 - $6,644	-79 Reduced 29.7%	187 $15,000
Q3 2022 Nov 02, 2022	SELL	$66.18 - $82.86 $8,404 - $10,523	-127 Reduced 32.32%	266 $18,000
Q2 2022 Aug 02, 2022	BUY	$66.18 - $83.18 $20,912 - $26,284	316 Added 410.39%	393 $30,000
Q1 2022 May 11, 2022	BUY	$66.02 - $79.71 $5,083 - $6,137	77 New	77 $6,000

642

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.